Forbion Capital Partners

Category:

Venture Capital

Description:

Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing drugs and technologies, with a clear focus on product development. The Forbion team is specialized in the evaluation of late stage preclinical / early stage clinical development programs. Forbion also invests in medical device companies with a focus on interventional cardiology and gastroenterology. The Forbion team began operating in 2000 as ABN AMRO Capital Life Sciences, the venture arm of ABN AMRO Bank NV. In December 2006 the group broadened its investor base, became independent, and changed its name to Forbion Capital Partners. Forbion currently has EUR 200 million under management.

Location:

Netherlands

Naarden

Industries:

🧬 Biotechnology

🏥 Health Care

Stages:

Seed

Series A

Series B

Series C

Series D

Series E

Notes:

Sector Restriction